Purespet | Custom Pet GPS Tracker & Health Monitor Manufacturer | OEM/ODM Services | AirTag Pet Collar
Seventy-eight percent of dogs with arthritis get a vet appointment when the disease has progressed past the early stage.
For many pet parents, the window before the diagnosis is when they are spending money on supplements, trying to switch foods, and finding brands they trust. That period can last for weeks and months.
The good news is your company can get in that window. Not by providing supplements. By giving pet parents something they lack before they go to the vet. Data on what has been happening with their dog.
Watching their dog that used to launch off the couch now lower down one leg at a time is when owners first notice it. They tell themselves it is nothing. But two days later, they Google “why does my dog hesitate before lying down.”
That is a customer for pet health monitoring devices. And right now, they do not know which brand to trust.
Arthritis in dogs is not rare. It is one of the most common conditions a general practitioner treats. At a roundtable on osteoarthritis prevalence published by DVM360, veterinary specialists estimated that as many as 50% of all dogs show clinical signs associated with osteoarthritis. According to Patton Veterinary Hospital, more than 15 million dogs in North America live with some form of degenerative joint disease.
The diagnosis almost always comes late. Research from Zoetis UK found that only 16% of vets report dogs being brought to them at the early stage of the disease. Seventy-eight percent of dogs are only presented to a vet once arthritis has already progressed past the early stage. Forty-five percent of pet owners believe arthritis is simply a normal part of aging, and 40% say they are not confident recognizing its early signs.
That gap between the first limping step and the first vet visit can take months. During that time, pet owners are researching, worrying, and buying. The brands that reach them in that window earn the longest customer relationships in the pet industry.
They do not wait. They act on incomplete information.
They read forum threads at midnight. They ask their vet, get a prescription, then spend three months second-guessing whether it's working. They buy a joint supplement because a breeder they follow mentioned it. They switch to a different food. They order a new bed, then a ramp, then a slow-feeder bowl because someone on a Facebook group said inflammation starts in the gut.
The Zoetis UK data adds a layer to this: 94% of vets believe online misinformation is eroding trust between vets and pet owners, and 66% of pet owners actively worry about inaccurate health information online. These are not passive buyers. They are anxious caregivers looking for a source they can believe - and spending money while they search.
What most pet brands give them: a product page. What they actually need: a way to see, clearly, whether their dog is getting better or worse.
The connection between arthritis and tracked movement is obvious. A 2010 veterinary study cited in a clinical review by PetJope found a statistically significant difference in activity levels between arthritic dogs on NSAIDs and those on a placebo - which means sensor data can reflect pain levels that owners cannot see. A preliminary analysis from the Pet Insight Project, published in Today's Veterinary Practice in 2019, used Whistle activity monitors on tens of thousands of dogs and found decreased activity patterns in dogs with osteoarthritis compared to the broader dog population.
In plain terms: a dog in pain moves differently, and a sensor picks that up before the owner does.
For a pet brand, this changes the product relationship. You are no longer selling something that addresses a problem the customer already knows about. You are selling the thing that shows them the problem exists, and then keeps showing them whether it is improving.
A customer who can see a trend line in their dog's daily step count over six weeks of using your joint supplement has something a standard customer never has: proof. That is also the most difficult thing to manufacture in marketing.
If your brand operates in the joint health space - supplements, mobility aids, prescription diets, therapeutics, orthotics, or any vet-adjacent product - you are already reaching customers who are either managing arthritis or worried about preventing it.
The question is whether you're giving them a reason to stay after the first purchase.
A health monitoring device solves that problem directly. It creates a continuous data relationship between the product and the owner. Daily readings. Baseline comparisons over time. Something concrete to bring to a vet appointment. The device becomes part of the dog's care routine, not a one-time transaction.
The brands that move into monitoring hardware - either by building it, white-labeling it, or bundling it - are not just adding a product. They are adding a data layer that makes every other product they sell more defensible.
Most wearable pet devices use an accelerometer - a motion sensor that counts steps and estimates activity. That is useful, but it has a ceiling. Reduced movement tells you something is wrong. It does not tell you what.
PuresPet's PHH-23 is built on BCG (ballistocardiography) technology. BCG reads the mechanical vibrations produced by the heartbeat, which means the device can monitor heart rate, respiratory rate, and HRV (heart rate variability) continuously, without electrode contact or skin prep. It runs 24 hours a day, seven days a week, and logs a BCG curve in real time.
For a dog with arthritis, that distinction matters. Pain changes resting vitals, not just stride length. A dog who is moving less because she hurts will also show shifts in resting heart rate and HRV that a step counter misses entirely. The PHH-23 catches both.
What it monitors:
The 4G Cat.1 connectivity is worth noting separately. This is not a Bluetooth-range device where data only syncs when the owner is nearby. Readings are transmitted and accessible in real time from anywhere - which matters for brands selling into veterinary recovery, mobility monitoring, or working-dog markets.
Device specs:
PuresPet sells to pet brands and businesses, not direct to consumer. The PHH-23 supports laser logo engraving, screen-printed branding, and fully customized packaging - which means you can bring this to market under your own brand name with production-ready packaging included.
Sampling lead time is 7-10 days. Production lead time is 20-25 days.
If you are evaluating the PHH-23 as a white-label device, a premium tier alongside your joint supplement line, or a branded monitor for customers managing chronic conditions, the product detail and B2B contact are at purespet.com.
You can review the product at purespet.com and contact PuresPet directly through the site to discuss B2B options.
No device diagnoses arthritis - that requires a vet exam and imaging. But activity trackers can detect the behavioral changes associated with joint pain: reduced step counts, longer rest periods, shorter play windows, altered gait patterns. A 2010 veterinary study found that activity data differed measurably between arthritic dogs on anti-inflammatory treatment versus those on a placebo, which means ongoing tracking can serve as an indicator of whether a treatment is working.
The pattern is usually a gradual drop in daily steps, longer stretches of inactivity, more time in resting postures, and reduced engagement in play. Devices that track vital signs may also show changes in resting heart rate or heart rate variability, both of which can shift with chronic pain. The most useful signal is the trend over time - not a single day's reading, but weeks of data that show a consistent direction.
They help owners see what is happening, which affects treatment compliance and vet conversations. A dog owner who brings six weeks of activity data to a vet appointment has something more useful than a vague description of "she seems slower." For pet brands selling arthritis-related products, activity data also creates the ability to show that the product is working - which is worth considerably more than a testimonial.
Beyond step-counting, the most relevant metrics for an arthritic dog are resting heart rate and respiratory rate (which can shift with chronic pain), sleep quality and duration, time spent in various postures, and the device's ability to establish an individual baseline over time. The goal is not general fitness tracking - it is a signal that tells you whether the dog's quality of life is changing in a sustained way.
The most common approaches are: bundling a device with a premium product tier, offering the device as a companion to a supplement or prescription diet, or building a data program where the tracking output connects to reorder recommendations. Some brands use the ongoing data as a retention mechanism - customers who actively track their dog's progress tend to stay significantly longer than customers who purchase once and move on.
Most consumer-grade trackers measure movement only. Devices that continuously monitor heart rate, respiratory rate, and biometric signals beyond steps typically come from veterinary-grade or health-monitoring-grade hardware. PuresPet's PHH-23, which uses BCG rather than standard accelerometer technology, sits in this category.
The signs are subtle and easy to rationalize as aging. A dog who takes longer to stand, skips one walk, or hesitates at the stairs does not look obviously sick. Research from Zoetis UK found that 45% of pet owners believe arthritis is a normal part of aging and that 28% wrongly believe dogs will always show obvious signs of pain. The average dog is only brought to the vet for arthritis once the disease has progressed, not at the first signs of stiffness.
The Zoetis UK research puts at least 2.98 million arthritic dogs in the UK alone. In North America, Patton Veterinary Hospital estimates more than 15 million dogs live with degenerative joint disease. These are dogs whose owners buy continuously - supplements, pain management aids, beds, ramps, food, and anything else that promises relief. The spend does not stop at diagnosis. It increases.
Related Articles:
Dedicated to the design, development and production of pet tracking products.
Contact: Collin Hu
Contact number: +86 13823767765
Email: collin@purespet.com
WhatsApp: +86 13823657765
Company Address: 3rd Floor, Building 6, Nanyu Industrial Park, Dalang Street, Longhua District, Shenzhen, China.
Shenzhen PureS Technology Co., Ltd.